CAS 1092939-17-7 appears in our catalog under these names: Ruxolitinib Phosphate, Ruxolitinib Phosphate, >95% (HPLC), Ruxolitinib phosphate/ 99.91% (existing batch purity), Ruxolitinib phosphate, Ruxolitinib . phosphate salt. Offered by: Chemat Brand, TRC, TargetMol, GLPBio, Biosynth. Available pack sizes: on request, 100mg, 10mg, 250mg, 1g, 5mg, 25mg, 50mg.
Ruxolitinib phosphate is a phosphate salt obtained by reaction ruxolitinib with one equivalent of phosphoric acid. Used for the treatment of patients with intermediate or high-risk myelofibrosis, including primary myelofibrosis, post-polycythemia vera myelofibrosis and post-essential thrombocythemia myelofibrosis. It has a role as an antineoplastic agent and an EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor. It contains a ruxolitinib.
Source: ChEBI
| Molecular formula | C17H21N6O4P |
|---|---|
| Molecular weight | 404.4 g/mol |
| IUPAC name | (3R)-3-cyclopentyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)pyrazol-1-yl]propanenitrile;phosphoric acid |
| InChIKey | JFMWPOCYMYGEDM-XFULWGLBSA-N |
| SMILES | C1CCC(C1)[C@@H](CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3.OP(=O)(O)O |
Computed by PubChem (NCBI)